Nexalin Technology Inc (NXL)

$0.34 +0.01 (1.92%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	7.49M
Revenue (ttm)	300,000.00
Net Income (ttm)	-8.22M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-2,740.00%
Debt to Equity Ratio	0.00

Volume	51,412
Avg Vol	213,802
Day's Range	N/A - N/A
Shares Out	22.04M
Stochastic %K	0%
Beta	4.00
Analysts	Strong Sell
Price Target	$2.00

Company Profile

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic br...

Industry: Medical Devices

Sector: Healthcare

Phone: 832 260 0222

Website: www.nexalin.com

Address:

1776 Yorktown, Suite 550, Houston, United States

Dante_s_Inferno Aug. 17 at 2:04 PM

$NXL management is on vacation ..pos

0 · Reply

focafoca99 Aug. 17 at 1:24 PM

$NXL awaits a Nasdaq hearing on its delisting notice scheduled for Sept. 1, 2026.

0 · Reply

MaskMaker Aug. 17 at 4:35 AM